Halozyme Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	316.89	444.09	281.59	202.13	402.71
Depreciation & Amortization	88.05	81.31	84.86	49.64	3
Stock-Based Compensation	51.57	43.39	36.62	24.4	20.82
Other Adjustments	347.31	-0.45	24.17	52.39	-130.07
Change in Receivables	-128.06	-74.25	-3.34	-83.94	6.76
Changes in Inventories	2.55	-67.38	-26.88	-17.48	7.37
Changes in Accounts Payable	6.21	46.99	-12.55	24.54	1.17
Changes in Unearned Revenue	-	-	-	-2.49	-0.75
Changes in Other Operating Activities	-32.96	5.36	4.1	-9.06	-11.56
Operating Cash Flow	651.56	479.06	388.57	240.11	299.44
Operating Cash Flow Growth	36.01%	23.29%	61.83%	-19.81%	439.98%
Capital Expenditures	-6.97	-10.7	-15.29	-4.81	-1.46
Sale of Property, Plant & Equipment	-	-	-	26.01	-
Purchases of Investments	-247.36	-647.6	-292.91	-255.21	-652.52
Proceeds from Sale of Investments	722.25	395.57	211.3	746.13	247.68
Payments for Business Acquisitions	-1,014	-	-	-999.12	-
Investing Cash Flow	-545.81	-262.72	-96.91	-487.01	-406.29
Short-Term Debt Issued	-	-	-	120	-
Short-Term Debt Repaid	-	-	-	-120	-
Long-Term Debt Issued	1,470	-	-	250	784.88
Long-Term Debt Repaid	-763.39	-	-13.48	-327.45	-369.06
Net Long-Term Debt Issued (Repaid)	706.61	-	-13.48	-77.45	415.81
Issuance of Common Stock	21.83	31.14	7.88	14.05	12.54
Repurchase of Common Stock	-342.37	-250	-392.38	-200	-350.06
Net Common Stock Issued (Repurchased)	-320.54	-218.86	-384.5	-185.95	-337.52
Other Financing Activities	-471.24	-	-	625.78	-0.42
Financing Cash Flow	-85.17	-218.86	-407.99	362.37	77.87
Net Cash Flow	20.57	-2.52	-116.33	115.48	-28.98
Free Cash Flow	644.59	468.37	373.28	235.3	297.98
Free Cash Flow Growth	37.62%	25.47%	58.64%	-21.04%	462.76%
FCF Margin	46.15%	46.13%	45.01%	35.65%	67.22%
Free Cash Flow Per Share	5.20	3.62	2.78	1.67	2.03
Levered Free Cash Flow	1,080	499.68	302.34	165	816.29
Unlevered Free Cash Flow	375.22	495.17	307.13	257.57	444.86

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.